Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Filgrastim

    ... It is known as a hematopoietic growth factor or colony stimulating factorand is given by injection under the skin ...

    Drug last updated 03/24/2016 - 12:32pm.

  2. Immunosuppressive Therapy

    ... in about 7 out of 10 cases. When a platelet growth factor called eltrombopag (Promacta®) is also given, more than 7 in 10 ...

    Topic section last updated 04/01/2016 - 2:24pm.

  3. BMT - Bone Marrow v Stem Cell Transplantation

    ... stem cells (PBSC) – The donor is given a white cell  growth factor  that increases the production of white blood cells and also dislodges ...

    Page last updated 02/23/2016 - 1:05pm.

  4. BMT - Bone Marrow v Stem Cell

    ... stem cells (PBSC) – The donor is given a white cell  growth factor  that increases the production of white blood cells and also dislodges ...

    Topic section last updated 02/23/2016 - 12:59pm.

  5. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... bone marrow myeloblasts and ANC > or = to 0.2 ( growth factor supported if necessary) at transplant work-up. Chronic ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  6. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... makes the donor unlikely to tolerate or cooperate with growth factor therapy and leukapheresis. Factors which place the donor at ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  7. Moderate, Severe, and Very Severe Aplastic Anemia: How are treatment decisions made?

    ... failure syndromes and the use of eltrombopag, a blood growth factor to treat aplastic anemia . She also studies familial causes ...

    Interview last updated 10/14/2015 - 12:47pm.

  8. Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children

    ... a donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It may also stop the patient's immune system from ... (GI) physician unless there is a clear precipitating factor (such as an azole, methotrexate, Bactrim or another drug); if the GI ...

    Clinical Trial last updated 06/13/2016 - 2:29pm.

  9. Selective Depletion of CD45RA+ Naive T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD

    ... a donor peripheral blood stem cell transplant helps stop the growth of cancer cells. It may also stop the patient's immune system from ... (GI) physician; unless there is a clear precipitating factor (such as an azole, methotrexate, Bactrim or another drug); if the GI ...

    Clinical Trial last updated 06/06/2016 - 2:55pm.

  10. Filgrastim, Cladribine, Cytarabine and Mitoxantrone With or Without Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome

    ... filgrastim ( granulocyte colony-stimulating factor [G-CSF]), cladribine, cytarabine, mitoxantrone hydrochloride, when given ... hydrochloride work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from ...

    Clinical Trial last updated 04/29/2016 - 1:03pm.